All News #Library
Biotech
Pneumagen Launches NeumoBind™ for Intranasal Therapeutics
17 Sep 2025 //
GLOBENEWSWIRE
Pneumagen Publishes Positive Phase 2 Data for Neumifil
02 Jul 2025 //
GLOBENEWSWIRE
Pneumagen Neumifil Influenza Data: Positive
23 May 2024 //
GLOBENEWSWIRE
Pneumagen: Neumifil Phase 2 Antiviral Data At ATS 2024
02 May 2024 //
GLOBENEWSWIRE
Pneumagen Announces Successful Clinical Proof of Concept for Neumifil
02 Oct 2023 //
GLOBENEWSWIRE
Pneumagen raises £8m to accelerate Phase 2 clinical development of Neumifil
01 Jun 2023 //
GLOBENEWSWIRE
Pneumagen further strengthens IP protection for lead product Neumifil
18 Apr 2023 //
GLOBENEWSWIRE

Market Place
Sourcing Support